LifeWealth Investments LLC bought a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 6,022 shares of the pharmacy operator's stock, valued at approximately $415,000.
A number of other institutional investors have also made changes to their positions in CVS. GAMMA Investing LLC lifted its position in shares of CVS Health by 198.5% during the first quarter. GAMMA Investing LLC now owns 18,669 shares of the pharmacy operator's stock worth $1,265,000 after purchasing an additional 12,415 shares in the last quarter. Valmark Advisers Inc. bought a new stake in shares of CVS Health in the first quarter worth $306,000. GHP Investment Advisors Inc. increased its stake in shares of CVS Health by 4.9% in the first quarter. GHP Investment Advisors Inc. now owns 56,835 shares of the pharmacy operator's stock worth $3,851,000 after buying an additional 2,677 shares during the last quarter. Asset Management One Co. Ltd. increased its stake in shares of CVS Health by 7.5% in the first quarter. Asset Management One Co. Ltd. now owns 514,355 shares of the pharmacy operator's stock worth $34,848,000 after buying an additional 35,894 shares during the last quarter. Finally, Legacy Advisors LLC increased its stake in shares of CVS Health by 17.3% in the first quarter. Legacy Advisors LLC now owns 7,608 shares of the pharmacy operator's stock worth $515,000 after buying an additional 1,124 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at CVS Health
In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares in the company, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 1.22% of the stock is owned by corporate insiders.
CVS Health Stock Down 1.2%
CVS Health stock opened at $82.08 on Thursday. The company has a 50-day simple moving average of $75.02 and a 200-day simple moving average of $68.45. The firm has a market capitalization of $104.11 billion, a P/E ratio of 22.93, a P/E/G ratio of 0.92 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. CVS Health Corporation has a one year low of $43.56 and a one year high of $83.52.
CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.
CVS Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date is Thursday, October 23rd. CVS Health's dividend payout ratio is currently 74.30%.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the stock. Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Sunday, September 21st. Truist Financial set a $92.00 target price on shares of CVS Health in a research note on Tuesday, October 14th. Weiss Ratings reiterated a "hold (c)" rating on shares of CVS Health in a research note on Tuesday, October 14th. Leerink Partners boosted their target price on shares of CVS Health from $86.00 to $95.00 and gave the company an "outperform" rating in a research note on Thursday, October 16th. Finally, Wells Fargo & Company boosted their target price on shares of CVS Health from $84.00 to $103.00 and gave the company an "overweight" rating in a research note on Tuesday, October 7th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of "Moderate Buy" and an average price target of $82.57.
Check Out Our Latest Stock Report on CVS
About CVS Health
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
